Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance
CNBC
Wed, 03/1/23 - 10:10 am
Tags:
Eli Lilly, drug pricing, diabetes, insulin, Humalog, Humalin
Big-sellers from Merck, Novo and Lilly likely to face Medicare price negotiations: report
Fierce Pharma
Tue, 02/28/23 - 10:39 pm
Tags:
Medicare, drug pricing, Merck, Novo Nordisk, Eli Lilly, Boehringer Ingelheim, JNJ
Eli Lilly's diabetes drug Mounjaro back in stock amid heightened obesity interest
Fierce Pharma
Wed, 02/22/23 - 06:51 pm
Tags:
Eli Lilly, Mounjaro, diabetes, obesity, drug shortages
Concert persuades FDA to keep breakthrough tag for alopecia therapy despite Lilly's arrival
Fierce Biotech
Wed, 02/15/23 - 10:48 am
Tags:
Concert Pharmaceuticals, alopecia areata, FDA, breakthrough therapy, deuruxolitinib, Eli Lilly, olumiant
Eli Lilly strikes 2nd deal to boost affordable insulin access, this time in Bangladesh
Fierce Pharma
Mon, 02/13/23 - 10:21 am
Tags:
Eli Lilly, Bangladesh, insulin, diabetes
Eli Lilly's employment decisions under fire once again as sales rep lodges age discrimination claim
Fierce Pharma
Thu, 02/9/23 - 06:38 pm
Tags:
Eli Lilly, age discrimination, legal, EEOC
Led by Merck, Vertex and Lilly, pharma's share prices largely climbed in '22 despite economic angst
Fierce Pharma
Tue, 02/7/23 - 12:00 pm
Tags:
Merck, Vertex Pharmaceuticals, Eli Lilly, pharma stocks
IgGenix sprints to clinic with peanut allergy candidate and additional $40M
Endpoints
Mon, 02/6/23 - 06:15 pm
Tags:
IgGenix, peanut allergy, funding, Eli Lilly
Lilly reports fast sales for new diabetes drug
BioPharma Dive
Thu, 02/2/23 - 11:07 pm
Tags:
Eli Lilly, Mounjaro, diabetes
Q4 earnings roundup: Merck, Lilly, Takeda and BMS release financials
Medical Marketing and Media
Thu, 02/2/23 - 10:55 am
Tags:
earnings, Merck, Takeda, Bristol Myers Squibb, Eli Lilly
Following in Lilly's footsteps, Teva takes 2nd long-acting schizophrenia drug into phase 3
Fierce Pharma
Tue, 01/31/23 - 12:31 pm
Tags:
Teva Pharmaceutical, clinical trials, schizophrenia, Eli Lilly, antipsychotics, Olanzapine, TV-44749
Lilly enters ripe BTK field with quick FDA nod in mantle cell lymphoma
Endpoints
Sun, 01/29/23 - 02:14 pm
Tags:
Eli Lilly, Btk inhibitors, FDA, Merck, mantle cell lymphoma, Jaypirca
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
Tags:
television ads, pharma marketing, DTC ads, AbbVie, Rinvoq, Dupixent, Sanofi, Regeneron, Skyrizi, Novo Nordisk, Ozempic, Jardiance, Eli Lilly, Boehringer Ingelheim, Rybelsus, Trulicity, Rexulti, Otsuka, Lundbeck, Tremfya, JNJ, Verzenio
Doubling down on diabetes drugs, Eli Lilly invests $450M into Research Triangle Park facility
Medical Marketing and Media
Tue, 01/24/23 - 06:34 pm
Tags:
Eli Lilly, North Carolina, diabetes, drug manufacturing, RTP
Some Experts Say FDA Made the Right Call on Lilly's Donanemab
BioSpace
Tue, 01/24/23 - 10:31 am
Tags:
Eli Lilly, FDA, Alzheimer's disease, donanemab
This Week at FDA: Pallone pushes for greater ClinicalTrials.gov enforcement, FDA rejects Eli Lilly Alzheimer’s drug, and more
RAPS.org
Sun, 01/22/23 - 01:00 pm
Tags:
FDA, regulatory, clinical trials, clinicaltrials.gov, Eli Lilly, donanemab, Medtronic, BeiGene, Seagen
Innovative Trial Design may have Cost Lilly’s Donanemab Accelerated Approval
BioSpace
Fri, 01/20/23 - 10:29 am
Tags:
Eli Lilly, donanemab, FDA, clinical trials, Alzheimer's disease, clinical trial design
Eli Lilly says U.S. FDA rejects accelerated approval for Alzheimer's drug
Yahoo/Reuters
Thu, 01/19/23 - 09:00 pm
Tags:
Eli Lilly, FDA, donanemab, Alzheimer's disease
A year of two halves for US approvals
EP Vantage
Thu, 01/19/23 - 09:38 am
Tags:
FDA, drug approvals, Mounjaro, Eli Lilly, Vabysmo, Roche, Opdualag, Bristol Myers Squibb, Carvykti, JNJ, Vtama, Roivant, Pluvicto, Novartis
Biopharma's stock market winners of 2022 revealed
EP Vantage
Wed, 01/18/23 - 09:46 am
Tags:
pharma stocks, Merck, Eli Lilly, AbbVie, Daiichi Sankyo, Vertex Pharmaceuticals, Takeda, Sarepta Therapeutics, Halozyme, Horizon Therapeutics

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.